Recombinant spider silk particles as drug delivery vehicles.

Spider silk has been in the focus of research mainly due to the superior mechanical characteristics of silk fibers. However, it has been previously shown that spider silk proteins can also adopt other morphologies such as submicroparticles. This study examines the applicability of such particles as drug carriers. Particle characterization revealed that particles made of the engineered spider silk protein eADF4(C16) are colloidally stable in solution. Here, it is shown that small molecules with positive net-charge can diffuse into the negatively charged spider silk protein matrix driven by electrostatic interactions. The loading efficiencies correlate with the distribution coefficient (logD) of small molecules of weak alkaline nature. Interestingly, constant release rates can be realized for a period of two weeks at physiological conditions in vitro, with accelerated release rates within acidic environments. Enzymatic degradation studies of eADF4(C16) particles indicated that the silk proteins degrade slowly and the particles decrease in size. Along with their all-aqueous and easy preparation, drug loaded eADF4(C16) particles provide a high potential for diverse applications in which controlled release from biodegradable carriers is desired.

[1]  Thomas Scheibel,et al.  Polymeric materials based on silk proteins , 2008 .

[2]  C. Laurencin,et al.  Biodegradable polymers as biomaterials , 2007 .

[3]  A. Piccoli,et al.  Serum elastase 1 in chronic pancreatic disease , 1985, Klinische Wochenschrift.

[4]  S. Garg,et al.  Bioadhesive microspheres as a controlled drug delivery system. , 2003, International journal of pharmaceutics.

[5]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[6]  J. Beisson,et al.  Preformed cell structure and cell heredity , 2008, Prion.

[7]  A. R. Kulkarni,et al.  Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Thomas Scheibel,et al.  Spider silk: from soluble protein to extraordinary fiber. , 2009, Angewandte Chemie.

[9]  Gerhard Winter,et al.  Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients , 1997 .

[10]  D. Kaplan,et al.  Silk microspheres for encapsulation and controlled release. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[11]  R. Arshady,et al.  Review : Biodegradable Microcapsular Drug Delivery Systems: Manufacturing Methodology, Release Control and Targeting Prospects , 1990 .

[12]  S. Gorb,et al.  An engineered spider silk protein forms microspheres. , 2008, Angewandte Chemie.

[13]  M. Wada,et al.  Mechanical properties of Silk fibroin-microcrystalline cellulose composite films , 2002 .

[14]  Thomas Scheibel,et al.  The elaborate structure of spider silk , 2008, Prion.

[15]  Robert Langer,et al.  Advances in Biomaterials, Drug Delivery, and Bionanotechnology , 2003 .

[16]  D. Speer,et al.  Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials. , 1980, Journal of biomedical materials research.

[17]  Ann-Christine Albertsson,et al.  Degradable polymer microspheres for controlled drug delivery , 2002 .

[18]  Young-Wook Won,et al.  Recombinant human gelatin nanoparticles as a protein drug carrier. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Thomas Scheibel,et al.  Spider silks: recombinant synthesis, assembly, spinning, and engineering of synthetic proteins , 2004, Microbial cell factories.

[20]  Lorenz Meinel,et al.  Silk fibroin spheres as a platform for controlled drug delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[21]  F. Vollrath,et al.  Local tolerance to spider silks and protein polymers in vivo. , 2002, In vivo.

[22]  A. Albertsson.  Degradable aliphatic polyesters , 2002 .

[23]  Hua-Jie Wang,et al.  Microspheres of corn protein, zein, for an ivermectin drug delivery system. , 2005, Biomaterials.

[24]  K. Shakesheff,et al.  Polymeric systems for controlled drug release. , 1999, Chemical reviews.

[25]  S. Ross,et al.  Colloidal Dispersions: Suspensions, Emulsions, and Foams , 2002 .

[26]  S. Tatulian,et al.  Infrared spectroscopy of proteins and peptides in lipid bilayers , 1997, Quarterly Reviews of Biophysics.

[27]  M. Ercan,et al.  Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Thomas Scheibel,et al.  Recombinant spider silk proteins for applications in biomaterials. , 2010, Macromolecular bioscience.

[29]  Y. Yamashiro,et al.  Increased serum trypsin and elastase-1 levels in patients undergoing L-asparaginase therapy , 1998, European Journal of Pediatrics.

[30]  D. Fischer,et al.  Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[31]  A. Jayakrishnan,et al.  Bioavailability of theophylline from glutaraldehyde cross-linked casein microspheres in rabbits following oral administration , 1995 .

[32]  V. Shah,et al.  Cross‐Linking of Gelatin Capsules and Its Relevance to Their in vitro‐ in vivo Performance , 1995 .

[33]  David L. Kaplan,et al.  Controlling silk fibroin particle features for drug delivery. , 2010, Biomaterials.

[34]  M. Schlosser,et al.  Immunogenicity of polymeric implants: long-term antibody response against polyester (Dacron) following the implantation of vascular prostheses into LEW.1A rats. , 2002, Journal of biomedical materials research.

[35]  P. M. Vogt,et al.  Spider silk fibres in artificial nerve constructs promote peripheral nerve regeneration , 2008, Cell proliferation.

[36]  G. Winter,et al.  Processing conditions for the formation of spider silk microspheres. , 2008, ChemSusChem.

[37]  R. Arletti,et al.  Gelatin microspheres crosslinked with D,L-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies. , 2001, International journal of pharmaceutics.

[38]  David L Kaplan,et al.  Silk-based biomaterials. , 2003, Biomaterials.

[39]  R. Rudolph,et al.  Primary structure elements of spider dragline silks and their contribution to protein solubility. , 2004, Biochemistry.

[40]  T. E. Abraham,et al.  Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[41]  S. Stolnik,et al.  COLLOIDAL STABILITY AND DRUG INCORPORATION ASPECTS OF MICELLAR-LIKE PLA-PEG NANOPARTICLES , 1999 .

[42]  Thomas Scheibel,et al.  Formulation of poorly water-soluble substances using self-assembling spider silk protein , 2008 .

[43]  S. Rammensee,et al.  Assembly mechanism of recombinant spider silk proteins , 2008, Proceedings of the National Academy of Sciences.

[44]  Paul E Tomlins,et al.  Biocompatibility and the efficacy of medical implants. , 2006, Regenerative medicine.

[45]  X. Zhu,et al.  Polymer microspheres for controlled drug release. , 2004, International journal of pharmaceutics.

[46]  M. Page,et al.  Serine Proteases and Serine Protease Inhibitors , 2008 .